Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Other peptides worth comparing: Liraglutide daily GLP-1 agonist, less effective than both but FDA-approved since 2014 Retatrutide triple agonist (GLP-1/GIP/Glucagon), showing up to 24% weight loss in Phase 2 trials AOD-9604 HGH fragment for fat metabolism, much milder effect The Bottom Line Tirzepatide has the edge in raw efficacy and tolerability based on trial data
By week 12, cumulative weight loss of 56% of baseline body weight is common in clinical trials, though individual results vary
If you've reached your weight loss goals on a GLP-1 and are wondering whether you'll need to stay on it forever, the answer is: not necessarily
Additionally, diabetes can impair the immune system, making it harder to fight off infections
The rate of excretion of salicylate is affected by urine pH
HIPAA SOC2 Type II LegitScript The data platform powering modern telehealth brands
